Nootropic startup removes brain disease claim on ASA ruling

By Will Chu

- Last updated on GMT

©Motion Nutrition
©Motion Nutrition

Related tags: Asa, Motion Nutrition, neurodegenerative

Motion Nutrition has addressed an Advertising Standards Authority (ASA) ruling which deemed a description of its nootropic supplement as a claim to be able to protect against neurodegenerative diseases.

Speaking to NutraIngredients, Joe Welstead, Motion Nutrition’s co-founder & CEO said of his ‘Power-up’ brain supplement, “Our goal is to support longevity and brain health as we grow old.

“It was presumptuous of us to mention any form of disease, and we were happy to remove any mention of this on the product page and in our advertising.

“Our goals with Power Up are twofold. The first is to improve mental performance on a daily basis - the “immediate” benefit, to which end we have an authorised health claim. The second is to support long term brain health - the “downstream” benefit.

“Still, recent scientific research documents how plant extracts used in Power Up (such as Gotu Kola) possess neuroprotective properties, and it would be shame not to explore these benefits.”

Original ruling

In March’s original ruling, the Advertising Standards Authority (ASA) denied the use of claims made for a product that purported to provide protection for the brain against neurodegenerative diseases.

Claims made on the website of sport nutrition firm MW Nutrition for a 30-day supply of capsules used accompanying text that stated: "Imagine … quietly helping your brain protect against degenerative diseases.”

ASA considered that consumers would understand the claim to mean the capsules could prevent degenerative diseases which affected the human brain, such as Parkinson’s disease.

Code prohibition

“While we acknowledged Motion Nutrition’s willingness to make changes to their advertising, we concluded the claims implied the product prevented, treated or cured human disease, which was prohibited under the Code,”​ ASA said.

“The ad must not appear again in the same form. We told MW Nutrition Ltd t/a Motion Nutrition to ensure future ads did not state or imply that a food could prevent, treat or cure human disease.”

The ad breaches CAP Code (Edition 12) rule 15.6.2 (Food, food supplements and associated health or nutrition claims), which states: “Claims that state or imply a food prevents, treats or cures human disease. Reduction-of disease-risk claims are acceptable if authorised by the European Commission.”

Related news

Show more

Related products

show more

DurOmega® Algal DHA 20% water dispersible powder

DurOmega® Algal DHA 20% water dispersible powder

INNOBIO Corporation Limited | 30-May-2022 | Technical / White Paper

INNOBIO most recently launched a new product DurOmega® Algal DHA 20% water dispersible powder with significantly reduced fishy odor and taste, which optimizes...

Total Solutions for Cognitive Health by Lubrizol

Total Solutions for Cognitive Health by Lubrizol

Lipofoods, a Lubrizol Company | 05-May-2022 | Technical / White Paper

Globally, health and wellbeing have shifted from a focus on physical health and nutrition to also include cognitive and mental wellness, therefore consumers...

Alesco, the Sucrosomial® company

Alesco, the Sucrosomial® company

Alesco S.r.l. | 29-Mar-2022 | Product Brochure

Alesco raw materials and functional ingredients offer unique, scientifically proven characteristics, suited for a wide range of needs in the pharmaceutical,...

Related suppliers

Follow us


View more